Joaquín M Prada1, Wilma A Stolk2, Emma L Davis3, Panayiota Touloupou4,5, Swarnali Sharma6, Johanna Muñoz2, Rocio M Caja Rivera6,7, Lisa J Reimer8, Edwin Michael6,7, Sake J de Vlas2, T Déirdre Hollingsworth3. 1. School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. 2. Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. 3. Big Data Institute, Li Ka Shing Center for Health Information and Discovery, Headington, Oxford, UK. 4. Department of Statistics, University of Warwick, Coventry, UK. 5. School of Mathematics, University of Birmingham, Birmingham, UK. 6. Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA. 7. Center for Global Health Infectious Disease Research, University of South Florida, Tampa, FL, USA. 8. Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Abstract
BACKGROUND: In view of the current global coronavirus disease 2019 pandemic, mass drug administration interventions for neglected tropical diseases, including lymphatic filariasis (LF), have been halted. We used mathematical modelling to estimate the impact of delaying or cancelling treatment rounds and explore possible mitigation strategies. METHODS: We used three established LF transmission models to simulate infection trends in settings with annual treatment rounds and programme delays in 2020 of 6, 12, 18 or 24 months. We then evaluated the impact of various mitigation strategies upon resuming activities. RESULTS: The delay in achieving the elimination goals is on average similar to the number of years the treatment rounds are missed. Enhanced interventions implemented for as little as 1 y can allow catch-up on the progress lost and, if maintained throughout the programme, can lead to acceleration of up to 3 y. CONCLUSIONS: In general, a short delay in the programme does not cause a major delay in achieving the goals. Impact is strongest in high-endemicity areas. Mitigation strategies such as biannual treatment or increased coverage are key to minimizing the impact of the disruption once the programme resumes and lead to potential acceleration should these enhanced strategies be maintained.
BACKGROUND: In view of the current global coronavirus disease 2019 pandemic, mass drug administration interventions for neglected tropical diseases, including lymphatic filariasis (LF), have been halted. We used mathematical modelling to estimate the impact of delaying or cancelling treatment rounds and explore possible mitigation strategies. METHODS: We used three established LF transmission models to simulate infection trends in settings with annual treatment rounds and programme delays in 2020 of 6, 12, 18 or 24 months. We then evaluated the impact of various mitigation strategies upon resuming activities. RESULTS: The delay in achieving the elimination goals is on average similar to the number of years the treatment rounds are missed. Enhanced interventions implemented for as little as 1 y can allow catch-up on the progress lost and, if maintained throughout the programme, can lead to acceleration of up to 3 y. CONCLUSIONS: In general, a short delay in the programme does not cause a major delay in achieving the goals. Impact is strongest in high-endemicity areas. Mitigation strategies such as biannual treatment or increased coverage are key to minimizing the impact of the disruption once the programme resumes and lead to potential acceleration should these enhanced strategies be maintained.
Authors: Anna Borlase; Epke A Le Rutte; Soledad Castaño; David J Blok; Jaspreet Toor; Federica Giardina; Emma L Davis Journal: Lancet Glob Health Date: 2022-11 Impact factor: 38.927
Authors: Stephanie McKay; Joy Shu'aibu; Abdourahim Cissé; Albi Knight; Fadhalu Abdullahi; Ahmed Ibrahim; Suzie Madaki; Chantelle Genovezos; Kate McCoy; Philip Downs; Achille Kabore; Helen Adamu; Ibrahim B Gobir; Michael Chaitkin; Claire J Standley Journal: PLoS Negl Trop Dis Date: 2021-12-20
Authors: Jessica Clark; Wilma A Stolk; María-Gloria Basáñez; Luc E Coffeng; Zulma M Cucunubá; Matthew A Dixon; Louise Dyson; Katie Hampson; Michael Marks; Graham F Medley; Timothy M Pollington; Joaquin M Prada; Kat S Rock; Henrik Salje; Jaspreet Toor; T Déirdre Hollingsworth Journal: Gates Open Res Date: 2022-02-02
Authors: Sarah Gwyn; Ado Abubakar; Oluwaseun Akinmulero; Eric Bergeron; Ugboaja Nkechi Blessing; Jasmine Chaitram; Melissa M Coughlin; Ayuba B Dawurung; Felicia Nwatu Dickson; Mudiaga Esiekpe; Erasogie Evbuomwan; Stacie M Greby; Nnaemeka C Iriemenam; Markus H Kainulainen; Thomas Andrew Naanpoen; Loveth Napoloen; Ifeanyichukwu Odoh; McPaul Okoye; Temitope Olaleye; Amy J Schuh; S Michele Owen; Awala Samuel; Diana L Martin Journal: Am J Trop Med Hyg Date: 2022-06-27 Impact factor: 3.707
Authors: Nicolas Pionnier; Julio Furlong-Silva; Stefano A P Colombo; Amy E Marriott; Valerine C Chunda; Bertrand L Ndzeshang; Hanna Sjoberg; John Archer; Andrew Steven; Samuel Wanji; Mark J Taylor; Joseph D Turner Journal: Front Immunol Date: 2022-09-27 Impact factor: 8.786
Authors: T Déirdre Hollingsworth; Pauline Mwinzi; Andreia Vasconcelos; Sake J de Vlas Journal: Trans R Soc Trop Med Hyg Date: 2021-03-06 Impact factor: 2.184